Harrow (HROW) EBIT Margin Growth (1y) (2014 - 2026)
Harrow (HROW) EBIT Margin Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -1,647.00 |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | -368.00 |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -17.00 |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | -341.00 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -634.00 |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | -538.00 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 40.00 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Harrow | 1.58 Bn | 1.49 Bn | 50.36 Mn | -3,348.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3,348.00 |
| Mar 31, 2026 | -2,647.00 |
| Dec 31, 2025 | -180.00 |
| Sep 30, 2025 | 1,790.00 |
| Jun 30, 2025 | 1,477.00 |
| Mar 31, 2025 | -345.00 |
| Dec 31, 2024 | 3,271.00 |
| Sep 30, 2024 | -241.00 |
| Jun 30, 2024 | -390.00 |
| Mar 31, 2024 | -2,467.00 |
| Dec 31, 2023 | -466.00 |
| Sep 30, 2023 | 550.00 |
| Jun 30, 2023 | -22.00 |
| Mar 31, 2023 | -486.00 |
| Dec 31, 2022 | -5.00 |
| Sep 30, 2022 | 1,945.00 |
| Jun 30, 2022 | -1,574.00 |
| Mar 31, 2022 | -939.00 |
| Dec 31, 2021 | -2,669.00 |
| Sep 30, 2021 | -3,096.00 |